Vireo Growth Inc. — Investor Relations & Filings
Filings indexed
543
across all filing types
Latest filing
2026-05-13
Regulatory Filings
Country
CA
Canada
Listing
CSE
VREO
Vireo Growth Inc. is a science-focused cannabis company that cultivates, processes, and distributes medical and adult-use cannabis products. The company emphasizes environmentally friendly cultivation practices, often utilizing greenhouses, and manufactures pharmaceutical-grade cannabis extracts. Vireo Growth operates wholesale and retail business lines, selling its portfolio of branded products through company-owned dispensaries and distribution networks. The company's mission is to provide safe access, quality products, and value to its customers, coupled with a commitment to community support and restorative justice programs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| News release - English.pdf | 2026-05-13 | English | |
| 52-109FV2 - Certification of interim filings - CEO (E).pdf | 2026-05-13 | English | |
| Interim MD&A - English.pdf | 2026-05-13 | English | |
| Interim financial statements/report – English.pdf | 2026-05-13 | English | |
| News release - English.pdf | 2026-04-30 | English | |
| Other.pdf | 2026-04-27 | English |
Browse filings by year
19 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47563437 | News release - English.pdf | 2026-05-13 | English | ||
| 47563442 | 52-109FV2 - Certification of interim filings - CEO (E).pdf | 2026-05-13 | English | ||
| 47563474 | Interim MD&A - English.pdf | 2026-05-13 | English | ||
| 47563478 | Interim financial statements/report – English.pdf | 2026-05-13 | English | ||
| 47563482 | News release - English.pdf | 2026-04-30 | English | ||
| 47563494 | Other.pdf | 2026-04-27 | English | ||
| 34694188 | Report of exempt distribution (45-106F1).pdf | 2026-04-20 | English | ||
| 34692876 | Report of exempt distribution (45-106F1).pdf | 2026-04-20 | English | ||
| 34651409 | Management information circular - English.pdf | 2026-04-16 | English | ||
| 34651408 | Other.pdf | 2026-04-16 | English | ||
| 34651407 | Form of proxy - English.pdf | 2026-04-16 | English | ||
| 34651406 | Notice of meeting - English.pdf | 2026-04-16 | English | ||
| 34650705 | Management information circular - English.pdf | 2026-04-16 | English | ||
| 34650704 | Other.pdf | 2026-04-16 | English | ||
| 34650703 | Form of proxy - English.pdf | 2026-04-16 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
Vireo Growth Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/45561/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=45561 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=45561 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=45561 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 45561}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Vireo Growth Inc. (id: 45561)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.